Estrella Immunopharma Inc - Warrants (29/09/2028)
ESLAW
Get informed when a big investor buys or sells
+ FollowMarket Cap$46.91M
Close$
$0.04
71.1% downside
Current Fair Value
71.1% downsideOvervalued by 71.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $46.91 Million |
|---|---|
| Enterprise Value | $44.98 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.35 |
| Beta | -0.09 |
| Outstanding Shares | 42,121,075 |
Return
| Return on Equity | 251.43% |
|---|---|
| Return on Assets | -362.33% |
| Return on Invested Capital | 249.36% |
Valuation & Multiples
| P/E Ratio | -3.46 |
|---|---|
| PEG | -38.83 |
| Price to Sales | - |
| Price to Book Ratio | -0.13 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -3.42 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
September 2, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 30,0000% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.35%▼ 0.06% |
|---|---|
| Total Invested | $37,165▲ 41.86% |
| Investors Holding | 9▼ 1.00% |
ESG Score
No data